| Follow Us: Facebook Twitter



3930 Varsity Dr
Ann Arbor, MI 48108

Adeona Pharmaceuticals

Adeona Pharmaceuticals is a development-stage, specialty pharmaceutical company that is developing orally active, proprietary, late-stage drug candidates for the treatment of autoimmune and central nervous system diseases.

Related Content

Adeona Pharma does $17.5M deal with Swedish drug maker Meda; seeks more partnerships

Corporate partnerships are the key words when it comes to Adeona Pharmaceuticals' future potential.The Ann Arbor-based drug development firm locked up a $17.5 million deal with Swedish drug maker Meda. Adeona Pharmaceuticals has five drugs in various stages of development and hopes to form another similar corporate partnership or two this year."The drugs are extremely exciting," says James Kuo, chairman and CFO of Adeona Pharmaceuticals. "They address the needs of large pharma."The 7-year-old company specializes in drugs that address problems in the central nervous system, such as multiple sclerosis and Alzheimer's, licensing those at the clinical stage to large pharmaceutical companies. It currently has a dozen employees and a few independent contractors, up from a headcount of seven early last year.Source: James Kuo, chairman and CFO of Adeona PharmaceuticalsWriter: Jon ZemkeRead more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com. read on…

Adeona Pharma buys Cali firm, plans to expand in Ann Arbor

Adeona Pharmaceuticals didn't just open an office in California, it bought one. The Ann Arbor-based firm recently paid handsomely (but smartly) for Colwell Clinical Laboratories in Southern California. Adeona plans to use the CLIA-certified clinical laboratory's services and test it has developed to expand an untapped part of its market."We're hoping to increase the type of testing they offer," says Steve Kanzer, chairman and CEO of Adeona Pharmaceuticals.Kanzer plans to leave Colwell's five people out in California. In the mean time he hopes to add another 5-10 people to Adeona's Ann Arbor operations within the next year or two. The company already employs seven people, some independent contractors and the occasional sumer intern. Adeona is a specialty pharmaceutical company specializing in awareness, diagnosis, prevention and treatment of subclinical zinc deficiency and chronic copper toxicity in the mature segment of the population.Source: Steve Kanzer, chairman and CEO of Adeona PharmaceuticalsWriter: Jon Zemke read on…
Signup for Email Alerts